Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Foscarnet Sodium vs Acyclovir in Herpes Zoster
NCT02151240Phase 4Completed
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- May 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of foscarnet sodium in herpes zoster (HZ), sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started May 2014; status: completed.
02
Drugs
foscarnet sodium
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT02151240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02151240.